AIRLINK 71.45 Decreased By ▼ -0.24 (-0.33%)
BOP 5.04 Increased By ▲ 0.04 (0.8%)
CNERGY 4.38 Decreased By ▼ -0.01 (-0.23%)
DFML 28.66 Increased By ▲ 0.11 (0.39%)
DGKC 83.10 Increased By ▲ 0.70 (0.85%)
FCCL 21.95 No Change ▼ 0.00 (0%)
FFBL 33.66 Decreased By ▼ -0.49 (-1.43%)
FFL 10.05 Decreased By ▼ -0.03 (-0.3%)
GGL 10.45 Increased By ▲ 0.33 (3.26%)
HBL 112.60 Decreased By ▼ -0.40 (-0.35%)
HUBC 140.80 Increased By ▲ 0.30 (0.21%)
HUMNL 8.53 Increased By ▲ 0.50 (6.23%)
KEL 4.61 Increased By ▲ 0.23 (5.25%)
KOSM 4.57 Increased By ▲ 0.07 (1.56%)
MLCF 38.19 Increased By ▲ 0.18 (0.47%)
OGDC 133.89 Decreased By ▼ -0.80 (-0.59%)
PAEL 26.37 Decreased By ▼ -0.25 (-0.94%)
PIAA 25.07 Decreased By ▼ -0.33 (-1.3%)
PIBTL 6.60 Increased By ▲ 0.05 (0.76%)
PPL 123.65 Increased By ▲ 1.70 (1.39%)
PRL 27.77 Increased By ▲ 0.04 (0.14%)
PTC 13.69 Decreased By ▼ -0.11 (-0.8%)
SEARL 55.45 Increased By ▲ 0.56 (1.02%)
SNGP 70.51 Increased By ▲ 0.81 (1.16%)
SSGC 10.39 Decreased By ▼ -0.01 (-0.1%)
TELE 8.47 Decreased By ▼ -0.03 (-0.35%)
TPLP 11.07 Increased By ▲ 0.12 (1.1%)
TRG 62.00 Increased By ▲ 1.10 (1.81%)
UNITY 25.21 Decreased By ▼ -0.01 (-0.04%)
WTL 1.33 Increased By ▲ 0.05 (3.91%)
BR100 7,641 Increased By 3 (0.04%)
BR30 25,062 Increased By 90.5 (0.36%)
KSE100 72,981 Increased By 219.5 (0.3%)
KSE30 23,644 Increased By 18.9 (0.08%)
Markets

Sanofi backs 50pc dividend payout long-term

NEW YORK : Sanofi SA's chief executive said that the drug-maker can maintain its dividend at a 50 percent payout ratio o
Published September 19, 2011

awsertNEW YORK: Sanofi SA's chief executive said that the drug-maker can maintain its dividend at a 50 percent payout ratio once it reaches that level and that large acquisitions are "completely off our radar screen."

"If you are going to make commitments on dividend policy you have to be prepared to make long term," Sanofi CEO Chris Viehbacher told Reuters in an interview on Monday.

The company, which is girding for generic competition for two of its top medicines, has said the dividend will go from its current 35 percent payout rate to the 50 percent range by no later than 2014.

Asked if Sanofi could maintain the dividend rate three or four years beyond 2014, Viehbacher said: "Oh yeah, we would move to 50 percent for a longer term."

The CEO also said he does not foresee significant generic competition to Sanofi's big-selling Lantus insulin for diabetics on the horizon, despite some concern by analysts that it could become vulnerable to generics by 2014.

Copyright Reuters, 2011

Comments

Comments are closed.